You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PDL-1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PDL1 In Primary Colorectal Carcinoma and Its Prognostic Impact

Not yet recruiting
  • PDL1- Colorectal Carcinoma
    • (no location specified)
    Jan 11, 2023

    HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With

    Not yet recruiting
    • Gastric Cancer
    • Observational
    • (no location specified)
    Dec 13, 2022

    Multiple Myeloma Trial (Bone marow biopsy and aspiration, biochemical and heamatological tests)

    Not yet recruiting
    • Multiple Myeloma
    • Bone marow biopsy and aspiration
    • biochemical and heamatological tests
    • (no location specified)
    Aug 9, 2023

    Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT

    Recruiting
    • Lung Cancer Stage III
    • Lung Cancer Stage IV
      • Brest, France
        Chu Brest
      Aug 16, 2023

      NSCLC, Solid Tumors, Programmed Cell Death-1 (PD1, PD-1) Trial (MK-2870, Pembrolizumab, Carboplatin)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • +4 more
      • MK-2870
      • +2 more
      • (no location specified)
      Sep 15, 2023

      NSCLC Trial (Phase I - Mirdametinib - Level 1, Phase II - Mirdametinib, Phase I - Mirdametinib - Level 2)

      Not yet recruiting
      • Non-Small Cell Lung Cancer
      • Phase I - Mirdametinib - Level 1
      • +4 more
      • (no location specified)
      Jul 7, 2023

      Acute Lymphoblastic Leukemia in Pediatric Trial in Sohag (flow cytometric immunophynotyping)

      Not yet recruiting
      • Acute Lymphoblastic Leukemia in Pediatric
      • flow cytometric immunophynotyping
      • Sohag, Egypt
        Sohag University Hospital
      Jun 19, 2022

      Skin Health and Quality of Life in Patients Receiving

      Not yet recruiting
      • Lung Cancer
      • +7 more
      • EQ-5D-5L questionnaire
      • +2 more
      • Roma, Italy
        Roberto Iacovelli
      May 17, 2023

      Advanced Tumors, Lymphoma, Metastatic Tumors Trial in Changchun, Jinan (HLX301)

      Recruiting
      • Advanced Tumors
      • +2 more
      • Changchun, Jilin, China
      • +1 more
      Jul 12, 2022

      Solid Tumor Malignancy, Hematologic Malignancy, Leukemia Trial run by the NCI (mrna 1273 injection)

      Recruiting
      • Solid Tumor Malignancy
      • +4 more
      • mRNA-1273
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 14, 2023

      NSCLC, Squamous Cell Carcinoma of the Head and Neck, Esophageal Squamous Cell Carcinoma Trial in San Antonio, West Valley City,

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • +4 more
      • San Antonio, Texas
      • +2 more
      Aug 15, 2022

      Primary Hepatocellular Carcinoma Trial (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), camrelizumab for

      Not yet recruiting
      • Primary Hepatocellular Carcinoma
      • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
      • camrelizumab for Injection
      • (no location specified)
      Nov 13, 2023

      PD1/PDL1 Inhibitors Treatment Duration in Patients With NSCLC

      Recruiting
      • Non-small Cell Lung Cancer
      • Monza, Italy
        ASST-Monza Ospedale San Gerardo
      Jun 9, 2022

      Advanced Gastroesophageal Adenocarcinoma, First-line Therapy, PDL1 CPS < 5 Trial (CAPOX combined with bevacizumab and

      Not yet recruiting
      • Advanced Gastroesophageal Adenocarcinoma
      • +2 more
      • CAPOX combined with bevacizumab and Tislelizumab
      • (no location specified)
      Mar 17, 2022

      Sarcoma Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))

      Recruiting
      • Sarcoma
      • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)
      • Beijing, China
        Peking University People's Hospital
      Nov 6, 2023

      Lung Cancer Trial in Assiut (Observational Study ( Tissue Biopsy ))

      Completed
      • Lung Cancer
      • Observational Study ( Tissue Biopsy )
      • Assiut, Egypt
        Assiut University
      Oct 18, 2021

      SOX2 & PDL1 Expression on Urinary Bladder Carcinoma

      Not yet recruiting
      • Urinary Bladder Neoplasm
        • (no location specified)
        Jun 17, 2022

        Metastatic Gastric Cancer Trial in Beijing (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)), Nivolumab

        Recruiting
        • Metastatic Gastric Cancer
        • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell))
        • Nivolumab Injection
        • Beijing, Beijing, China
          Peking University Cancer Hospital
        Aug 23, 2023

        Cancer Trial in Besancon (Biological samples, Anti PD1/PDL1 treatment)

        Recruiting
        • Cancer
        • Biological samples
        • Anti PD1/PDL1 treatment
        • Besancon, France
          University Hospital of Besançon
        Jul 30, 2021

        Chemo, Radiation Therapy Trial in Fuzhou (Camrelizumab, Paclitaxel, Cisplatin)

        Not yet recruiting
        • Chemotherapy
        • Radiation Therapy
        • Fuzhou, China
          Fujian Medical University Union Hospital
        Apr 6, 2023

        Solid Tumor Trial in Richmond (Stereotactic radiotherapy, Biological: humanized anti-PD-1 mAb, Biological: humanized anti-PD-L1

        Completed
        Has Results
        • Solid Tumor
        • Stereotactic radiotherapy
        • +2 more
        • Richmond, Virginia
          Virginia Commonwealth University/Massey Cancer Center
        Dec 20, 2021

        Cervical Cancer Trial in Wuhan (Recombinant humanized anti-PD-1 mAb injection, Cisplatin, Bevacizumab Injection)

        Not yet recruiting
        • Cervical Cancer
        • Recombinant humanized anti-PD-1 monoclonal antibody injection
        • +4 more
        • Wuhan, Hubei, China
          Tongji Hospital affiliated to Tongji Medical College of Huazhong
        Nov 3, 2023

        Locally Advanced or Metastatic Solid Tumors, NSCLC Trial in Australia (HLX301)

        Recruiting
        • Locally Advanced or Metastatic Solid Tumors
        • Non-small Cell Lung Cancer
        • Blacktown, New South Wales, Australia
        • +4 more
        May 25, 2022

        Urothelial Carcinoma Trial in Ann Arbor (Pembrolizumab, Abraxane)

        Active, not recruiting
        • Urothelial Carcinoma
        • Ann Arbor, Michigan
          University of Michigan Comprehensive Cancer Center
        Dec 15, 2021

        Sarcoma,Soft Tissue Trial in France (Cobimetinib, Atezolizumab)

        Recruiting
        • Sarcoma,Soft Tissue
        • Angers, France
        • +4 more
        Mar 28, 2022